Literature DB >> 10817791

Absence of relationship between tuberculin reactivity and atopy in BCG vaccinated young adults.

E Omenaas1, H F Jentoft, W M Vollmer, A S Buist, A Gulsvik.   

Abstract

BACKGROUND: An inverse association between tuberculin responses and atopy has been observed in Japanese children, indicating that BCG immunisation, subclinical exposure to Mycobacterium tuberculosis without clinical disease, or host characteristics may influence the T helper (Th) lymphocyte balance with decreased atopy as a result. This study was undertaken to determine whether tuberculin reactivity is inversely related to atopy in young adults vaccinated with BCG at the age of 14.
METHODS: Men and women aged 20-44 years were tested using the adrenaline-Pirquet test with Norwegian produced synthetic medium tuberculin (n = 891). In addition, their serum total and specific IgE antibodies against mite, cat, timothy grass, mould and birch were measured.
RESULTS: Of the 574 subjects with complete examinations, 64% had a positive adrenaline-Pirquet tuberculin test (> or =4 mm) and 27% exhibited IgE antibodies (> or =0.35 kU/l) to one or more of the five specific allergens. The geometric mean of total serum IgE in the population was 30.2 kU/l. Tuberculin reactivity and log IgE were not correlated (r = 0.043, p = 0.30). The mean tuberculin reactivity was 4.6 mm, 4.9 mm, and 5.0 mm in the lower, middle and upper tertile of IgE distribution (<14 kU/l, 14-61 kU/l, >61 kU/l). The prevalence of atopy, as assessed by either the presence of any of the five specific IgE antibodies or by each specific IgE antibody separately, did not differ between subjects with a positive and those with a negative tuberculin test. These results persisted after adjustment for age, sex, and smoking status in multivariate logistic regression analyses.
CONCLUSIONS: In this young adult population, BCG vaccinated at the age of 14, no significant relationship between a positive tuberculin reaction and atopy was observed. If a true relationship had been found, our study suggests that it may be limited to populations immunised in early childhood when a substantial modulation of the immune system can occur.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10817791      PMCID: PMC1745773          DOI: 10.1136/thorax.55.6.454

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  13 in total

Review 1.  Induction of TH1 and TH2 responses: a key role for the 'natural' immune response?

Authors:  S Romagnani
Journal:  Immunol Today       Date:  1992-10

2.  Early BCG vaccination and development of atopy.

Authors:  J S Alm; G Lilja; G Pershagen; A Scheynius
Journal:  Lancet       Date:  1997-08-09       Impact factor: 79.321

3.  The risk of tuberculous infection in Norway.

Authors:  H Waaler; O Galtung; K Mordal
Journal:  Bull Int Union Tuberc       Date:  1975

4.  Asthma: an epidemic in the absence of infection?

Authors:  W O Cookson; M F Moffatt
Journal:  Science       Date:  1997-01-03       Impact factor: 47.728

5.  BCG vaccination and atopy--unfinished business?

Authors:  M Silverman
Journal:  Lancet       Date:  1997-08-09       Impact factor: 79.321

6.  Tuberculin test variability: using the Norwegian Adrenaline-Pirquet method.

Authors:  H F Jentoft; E Omenaas; G E Eide; A Gulsvik
Journal:  Int J Tuberc Lung Dis       Date:  1999-04       Impact factor: 2.373

7.  The inverse relationship between tuberculin responses and atopic disorder.

Authors:  L C Martinati; A L Boner
Journal:  Allergy       Date:  1997-10       Impact factor: 13.146

8.  Mycobacterial infections in Norway: a preliminary note on determining their identity and frequency.

Authors:  T Bjerkedal
Journal:  Am J Epidemiol       Date:  1967-01       Impact factor: 4.897

9.  The inverse association between tuberculin responses and atopic disorder.

Authors:  T Shirakawa; T Enomoto; S Shimazu; J M Hopkin
Journal:  Science       Date:  1997-01-03       Impact factor: 47.728

10.  Total and specific serum IgE levels in adults: relationship to sex, age and environmental factors.

Authors:  E Omenaas; P Bakke; S Elsayed; R Hanoa; A Gulsvik
Journal:  Clin Exp Allergy       Date:  1994-06       Impact factor: 5.018

View more
  9 in total

Review 1.  Family size, infection and atopy: the first decade of the "hygiene hypothesis".

Authors:  D P Strachan
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

Review 2.  The future of asthma therapy: integrating clinical and experimental studies.

Authors:  David B Corry; Farrah Kheradmand
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  BCG infection in allergen-presensitized rats suppresses Th2 immune response and prevents the development of allergic asthmatic reaction.

Authors:  Y I Koh; I S Choi; W Y Kim
Journal:  J Clin Immunol       Date:  2001-01       Impact factor: 8.317

Review 4.  The potential of Mycobacterium to protect against allergy and asthma.

Authors:  Charles C Obihara; Jan L L Kimpen; Nulda Beyers
Journal:  Curr Allergy Asthma Rep       Date:  2007-06       Impact factor: 4.806

5.  Asthma, atopy and tuberculin responses in Chinese schoolchildren in Hong Kong.

Authors:  G W Wong; D S Hui; C M Tam; H H Chan; T F Fok; M Chan-Yeung; C K Lai
Journal:  Thorax       Date:  2001-10       Impact factor: 9.139

Review 6.  Does a higher number of siblings protect against the development of allergy and asthma? A review.

Authors:  W Karmaus; C Botezan
Journal:  J Epidemiol Community Health       Date:  2002-03       Impact factor: 3.710

Review 7.  Too clean, or not too clean: the hygiene hypothesis and home hygiene.

Authors:  S F Bloomfield; R Stanwell-Smith; R W R Crevel; J Pickup
Journal:  Clin Exp Allergy       Date:  2006-04       Impact factor: 5.018

Review 8.  The Humoral Immune Response to BCG Vaccination.

Authors:  Rachel Tanner; Bernardo Villarreal-Ramos; H Martin Vordermeier; Helen McShane
Journal:  Front Immunol       Date:  2019-06-11       Impact factor: 7.561

Review 9.  Environmental contributions to the allergic asthma epidemic.

Authors:  Farrah Kheradmand; Kirtee Rishi; David B Corry
Journal:  Environ Health Perspect       Date:  2002-08       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.